| Financial Year |
March 31 2023 |
| Monetary Funds |
226,470,826.02 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
1,423,831.73 |
| Accounts Receivable |
679,226,413.44 |
| Advances to Suppliers |
77,632,716.21 |
| Other Receivables |
1,432,661,168.85 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
243,716,715.37 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
13,131,381.18 |
| Total Current Assets |
2,748,997,200.09 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
9,604,375.80 |
| Fixed Assetes |
1,086,151,524.41 |
| Under-construction Projects |
9,160,339.11 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
326,645,388.41 |
| R&D expenses |
15,915,562.54 |
| Goodwill |
826,287,819.54 |
| Long-Term Deferred and Prepaid Expenses |
13,924,337.13 |
| Deferred Income Tax Assets |
58,481,884.36 |
| Other Non-Current Assets |
25,697,304.51 |
| Sub-Total of Non-Current Assets |
2,389,161,533.62 |
| Total Assets |
5,138,158,733.71 |
| Short-Term Loans |
1,012,163,025.50 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
125,222,588.57 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
14,165,315.04 |
| Taxes Payable |
48,042,803.23 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
210,255,040.17 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
367,397,971.96 |
| Other Current Liabilities |
4,105,268.97 |
| Sub-Total of Current Liabilities |
1,812,931,005.53 |
| Long-term Loans |
504,396,447.89 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
128,000,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
49,718,015.74 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
683,590,793.32 |
| Total Liabilities |
2,496,521,798.85 |
| Paid-In Capital(Or Share Stock) |
1,182,212,982.00 |
| Capital Surplus |
528,044,115.47 |
| Surplus Reserve |
77,102,308.81 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
784,629,027.97 |
| Minority Stockholder's Interest |
69,648,500.61 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,571,988,434.25 |
| Owner's Equity（Stockholder's Equity） |
2,641,636,934.86 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,138,158,733.71 |
